Diversity & Inclusion Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Beyond the Breakthrough: The Manufacturing Work That Gets Medicines and Vaccines to Patients
Scientific discoveries form the basis of every medical breakthrough. But transforming those discoveries into medicines that reach patients requires another kind of innovation: manufacturing.Behind every dose, a complex global network of manufacturing sites, supply chain experts, quality teams, and logistics specialists work together to produce medicines consistently, reliably, and at the scale patients need. These efforts often happen behind the scenes, but they play a critical role in expanding...
July Social Media Round-Up—America 250, Pfizer Futures, and More
Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.Last month, we held important conversations around living with alopecia areata, shared the story of a Pfizer colleague and cancer survivor, and reflected on the changes in science over the years.CEO Albert Bourla celebrated America’s 250th birthday, shared advice for our outgoing Pfizer Futures class, and congratulated the World Cup winners. While our leadership team shared...
Exploring the Latest Advances in Menstrual Migraine Research
For millions of people who menstruate, migraine attacks don’t always strike at random. For many, they’re more likely to occur in and around the days of the menstrual period, driven in part by the hormonal shifts of the cycle. When migraine attacks consistently occur on or around menstruation, the pattern has a name—menstrual migraine—and it’s more than just a bad headache.Research suggests migraine attacks that occur during the menstrual period are often more disabling relative to those that...
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council...
Menstrual Migraine Explained: Why They Happen and What Can Help
For some people, migraine attacks aren’t random. Instead, they follow predictable hormonal rhythms that unfold over time. Menstrual migraine is a common type of migraine, yet it’s still a condition many aren’t familiar with.1Compared with other types of migraine, menstrual-related migraine may cause more severe symptoms.1 Understanding how and why these migraine attacks occur can help you anticipate symptoms before they begin and work with your doctor to better manage them.Understanding...
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More
April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire.In April, Pfizer colleagues were honored in the list of 2026 Healthcare Businesswomen’s Association (HBA) Luminaries and Rising Stars, we recognized vaccines’ impact during World Immunization Week, and Pfizer scientists highlighted our research efforts.CEO Albert Bourla recognized Pfizer scientists who were...
March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More
Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels.This March, we received another accolade (Ethisphere recognized Pfizer as one of the World’s Most Ethical Companies for the fifth year in a row), shared new episodes of “Science Will Win” and “What’s In My Lab”, and provided a behind-the-scenes look at our commitment to fighting cancer.We also published our 2025 Annual Review, with opening remarks from CEO Albert Bourla, while...
February Social Media Round-Up—World Cancer Day, Science Will Win, and More
The groundhog may have predicted six more weeks of winter, but here at Pfizer we’re predicting blue skies ahead as we wrap up another great month.We kicked off February with the launch of season six of “Science Will Win”—Pfizer’s award-winning podcast, announced the launch of The Empowering Women in IBD Leadership program, shared positive results in an ongoing study in patients with metastatic colorectal cancer, and much more.CEO Albert Bourla celebrated World Cancer Day by highlighting the...
January Social Media Round-Up—2026 Strategic Priorities, Clinical Trials, and More
The new year is off to an exciting start here at Pfizer!Already this year, we launched a new episode of “Rewrite the Recipe,” shined a light on the story of a lung cancer patient, The Pfizer Foundation has expanded its Action & Impact initiative, and that’s just the beginning.During a busy trip to Davos, CEO Albert Bourla shared Pfizer’s strategic priorities for the year, sat down with The Wall Street Journal to discuss how the healthcare landscape is changing, and joined industry experts for...
Hiding in Plain Sight: The Racial Toll of Lyme Disease
Lyme disease is the most common vector-borne illness in the United States.1 Caused by the bacteria Borrelia burgdorferi sensu lato and spread through infected tick bites, it affects an estimated 476,000 Americans each year.1,3Yet the burden of Lyme disease, particularly the experience of a timely diagnosis, isn’t shared equally.Despite its prevalence, the face of Lyme disease in public health data is overwhelmingly white. In the United States, surveillance data shows that over 90% of Lyme...
December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More
Happy New Year! Pay some final respects to 2025 with our monthly look back at Pfizer’s social channels.In the final month of the year, Pfizer shared an exciting innovation in cancer research, highlighted challenges faced by community-based organizations, and raised awareness for Alopecia Areata and sickle cell.Meanwhile, CEO Albert Bourla recognized the Pfizer team for our accomplishments in 2025 and shared his optimism for the upcoming year, highlighted our presence at major conferences, and...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.